Cytotoxic preparations & chemotherapy
Cytotoxic preparations and chemotherapy: zero compromise on precision
In an oncology department, even the slightest dosage error can have a major impact on therapeutic efficacy and treatment tolerance. With QCRx®, you can secure your chemotherapy preparations while reducing the pressure on your teams.
Specific issues of chemotherapy
To understand the usefulness of dedicated analytical control, it is essential to recall the particularities of these treatments.
Cytotoxic drugs have a narrow therapeutic window: underdosing reduces efficacy, overdosing increases toxicity. They therefore require precise dosing and flawless traceability.
Cytotoxics: why is increased monitoring essential?
These characteristics explain why enhanced control can only be a strategic priority.
- High toxicity;
- Risks of exposure for staff;
- Inter- and intra-patient variability;
- Need to prove conformity for each batch.
Use of QCRx® in an oncological context
Icones Services’ technological response combines precision, speed and ease of integration.
QCRx®’s UV/Raman spectrum confirms the concentration in less than 70 seconds and transmits the information to the DPI. The pharmaceutical preparation is released immediately, with no waiting time.
Precise dosage, compliance, patient safety
This result directly improves patient safety and your pharmacy’s performance. For more details on the quantified impact, also see the Dosage and Chemotherapy page.
Our customers see an average deviation of <0.1% between the QCRx® result and the prescription, compared to 1-2% with semi-manual methods.
These figures are based on actual deployments in cancer centers.
Case studies in cancer centers
- Center A: 30% reduction in cycle time, 0 critical deviations during the ANSM audit.
- Center B: reduction from 5 to 1 weekly re-sampling thanks to systematic monitoring.
- Center C: integrated GPI-Pharmagest traceability, doctor/pharmacist satisfaction: 9.2/10.
Test our chemotherapy solution
Would you like to test the performance of our solution on your technical platform? Let’s put it to the test now.